PPD brings extensive experience in the nuances of post-approval studies, combined with a solid foundation in late-stage clinical trials management.
Extensive knowledge of hematology and oncology research, vast capabilities and experience with feasibility studies and a large investigator network.
PPD conducts clinical trials around the world that involve the testing of new drugs or delivery methods to determine safety and effectiveness.
Get information about PPD posted on industry websites and publications.
Heather Myler, Ph.D., director, PPD Laboratories, bioanalytical lab, and Peter Wunderli, Ph.D., research fellow, PPD Laboratories, GMP lab, explain cell and gene therapy trials' complexities.
Heather Myler, Ph.D., director, PPD Laboratories, bioanalytical lab, and Peter Wunderli, Ph.D., research fellow, PPD Laboratories, GMP lab, talk about harmonization of language in the field.
Elisha Talley-Roithner, global head of operations, PPD Biotech, discusses PPD Biotech’s Biotech University and its unique training capabilities.
Shefali Shah, principal of market access consulting, Evidera, and John Rafa, senior director of market intelligence, Accelerated Enrollment Solutions (AES), write about payer/health technology perspectives and trial design, optimal approaches for incorporating feedback and more.
Linda Ross, senior director, peri- and post-approval operations, Evidera, discusses how registries can be an incredibly useful tool in research.
We want to hear from you
Register in PPD's Database
© 2019 Pharmaceutical Product Development, LLC. All rights reserved.